CD47 is Required for Mesenchymal Progenitor Proliferation and Fracture Repair
Robert L. Zondervan, Christina A. Capobianco, Daniel C. Jenkins, John D. Reicha, Livia M. Fredrick, Charles Lam, Jeanna T. Schmanski, Jeffery S. Isenberg, Jaimo Ahn, Ralph Marcucio, Kurt David Hankenson
This study shows that CD47 inhibition impairs bone fracture healing by reducing mesenchymal stem cell proliferation, despite increased endothelial cell proliferation.
Bone Research · Mar 2, 2025Peer-reviewedMolecular Biology